Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Naohiko Okada"'
Autor:
Toshiaki Kamimura, Kazuyo Miki, Naohiko Okada, Minoru Nishida, Yoshiko Yokota, Hiroshi Sakamoto, Shigemi Fukada, Shoji Nakamoto, Takeo Murakawa
Publikováno v:
The Journal of Antibiotics. 29:444-459
FR10612, like cephalexin, is a broad-spectrum oral cephalosporin derivative. The antimicrobial activity of FR10612 against clinical isolates was similar to cephalexin; however, at a low inoculum size its activity was greater than cephalexin against K
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82ae7cdd14765d69b8dcb7a3341dd222
https://doi.org/10.7164/antibiotics.29.444
https://doi.org/10.7164/antibiotics.29.444
Autor:
Minoru Nishida, B.D. Rawal, K.R. Comber, Yohko Kohno, Tom Bergan, F. Fried, B.G. Charles, H. Held, Walter H. Traub, G.H. Valler, Hiroshi Sakamoto, Yoshiko Yokota, Ingrid Kleber, Takeo Murakawa, R. Sutherland, Naohiko Okada, M.J. Basker
Publikováno v:
Chemotherapy. 23:I-VI
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9968a2bad0c0cfd1700ad53874f08645
https://doi.org/10.1159/000222008
https://doi.org/10.1159/000222008
Autor:
Hiroshi Sakamoto, Yoshiko Yokota, Shoji Nakamoto, Yoko Kono, Toshiaki Kamimura, Takeo Murakawa, Shigemi Fukada, Naohiko Okada, Minoru Nishida
Publikováno v:
Antimicrobial Agents and Chemotherapy. 11:51-63
FR10024 is a broad-spectrum antibiotic. The in vitro antibacterial activity of FR10024 against clinical isolates of Staphylococcus aureus, Escherichia coli, Klebsiella pneumoniae , and Proteus mirabilis is greater than that of any of the cephalospori
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2fc51b43e264a744374b8f11ba6e4e1
https://doi.org/10.1128/aac.11.1.51
https://doi.org/10.1128/aac.11.1.51
Autor:
Sachiko Goto, Naohiko Okada, Minoru Nishida, Toshiaki Kamimura, Yoshimi Matsumoto, Y Mine, Shogo Kuwahara
Publikováno v:
Antimicrobial Agents and Chemotherapy. 16:540-548
FK 749 is a new parenteral cephalosporin derivative which is more active against various gram-negative bacilli, including the opportunistic pathogens such as Enterobacter, Citrobacter species, and Serratia marcescens, than cephalosporins and cephamyc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bdfbdbdb5fddcceedd9c57270daed527
https://doi.org/10.1128/aac.16.5.540
https://doi.org/10.1128/aac.16.5.540
Publikováno v:
Antimicrobial agents and chemotherapy. 14(1)
The bactericidal activity of cefazolin, cephaloridine, and cephalothin in a simulated intramuscular study (500 mg) and a simulated intravenous drip infusion study (2 g/2 h) is reported. In both model systems, the bactericidal activity of cefazolin su
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4af081aec9afb9c77d048691219e807d
https://pubmed.ncbi.nlm.nih.gov/356725
https://pubmed.ncbi.nlm.nih.gov/356725
Publikováno v:
Chemotherapy. 23(6)
Serum levels of FR10612 given orally to rats persisted significantly longer than did those of cephalexin. Since the elucidation of this phenomenon observed in rats is considered to be pertinent to the understanding of the drug kinetics of FR10612 in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7711daa145248b9ef275ffd3c3b7f073
https://pubmed.ncbi.nlm.nih.gov/923331
https://pubmed.ncbi.nlm.nih.gov/923331